Assesses adults 18 years of age and older during the measurement year who were hospitalized and discharged alive with a diagnosis of acute myocardial infarction and who received persistent beta-blocker treatment for six months after discharge.
Why It Matters
Every 34 seconds, someone in the United States has a heart attack.¹ A heart attack, or myocardial infarction, occurs when blood flow to the heart is greatly reduced or stops completely.² Clinical guidelines recommend taking a beta-blocker after a heart attack to prevent another heart attack from occurring.³ Beta-blockers work by lowering the heart rate. This reduces the amount of force on the heart and blood vessels.4 Persistent use of a beta-blocker after a heart attack can improve survival and heart disease outcomes.
Results – National Averages
Persistence of Beta-Blocker Treatment After A Heart Attack (PBH)
| Measure Year | Commercial HMO | Commercial PPO | Medicaid HMO | Medicare HMO | Medicare PPO |
|---|---|---|---|---|---|
| 2022 | 85.1 | 85.9 | 79.9 | 89.1 | 88.8 |
| 2021 | 85.3 | 85.6 | 80.7 | 88.8 | 89.6 |
| 2020 | 85.9 | 86.6 | 80.4 | 88.8 | 91.3 |
| 2019 | 85.1 | 85.6 | 80.9 | § | § |
| 2018 | 82.1 | 82.8 | 75.9 | 87.1 | 89.1 |
| 2017 | 85.4 | 84.0 | 78.5 | 90.0 | 90.7 |
| 2016 | 84.4 | 83.8 | 79.9 | 90.1 | 89.9 |
| 2015 | 84.8 | 82 | 80.5 | 90.9 | 90.8 |
| 2014 | 84.4 | 81.8 | 83.3 | 90.5 | 89.2 |
| 2013 | 83.9 | 81.4 | 84.2 | 90.0 | 89.4 |
| 2012 | 83.9 | 79.5 | 82.0 | 88.9 | 88.5 |
| 2011 | 81.3 | 77 | 80.5 | 87.3 | 86.2 |
| 2010 | 75.5 | 71.3 | 76.3 | 83.1 | 82.5 |
| 2009 | 74.4 | 69.6 | 76.6 | 82.6 | 78.9 |
| 2008 | 75 | 68.8 | 73.6 | 79.7 | 76.7 |
| 2007 | 71.9 | 62.9 | 62.0 | 75.5 | 70.4 |
| 2006 | 72.5 | 65.5 | 68.1 | 69.6 | 70.9 |
| 2005 | 70.2 | 64.3 | 69.8 | 65.4 | 58.5 |
§ Not available due to CMS suspension of data reporting during COVID-19 pandemic.
This State of Healthcare Quality Report classifies health plans differently than NCQA’s Quality Compass. HMO corresponds to All LOBs (excluding PPO and EPO) within Quality Compass. PPO corresponds to PPO and EPO within Quality Compass.
Figures do not account for changes in the underlying measure that could break trending. Contact Information Products via my.ncqa.org for analysis that accounts for trend breaks.
References
- Go, A.S., D. Mozaffarian, V. L. Roger, E. J. Benjamin, J. D. Berry, et al. 2014. “Heart disease and stroke statistics—2014 update: a report from the American Heart Association.” Circulation 129:e28-e292. doi: 10.1161/01.cir.0000441139.02102.80
- American Heart Association (AHA). 2016. “About Heart Attacks.” https://www.heart.org/en/health-topics/heart-attack/about-heart-attacks
- Yancey, C.W., M. Jessup, B. Bozkurt, J. Butler, D.E. Casey, M.H. Drazner, G.C. Fonarow, et al. 2013. “ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” Circulation 128:e240–e327.
- AHA. 2013. “How do beta blocker drugs affect exercise?” http://www.heart.org/HEARTORG/Conditions/More/MyHeartandStrokeNews/How-do-beta-blocker-drugs-affect-exercise_UCM_450771_Article.jsp